Monitoring antimalarial safety and tolerability in clinical trials: A case study from Uganda

Sarah G Staedke^1,2 , Prasanna Jagannathan³ , Adoke Yeka⁴ , Hasifa Bukirwa⁴ , Kristin Banek⁴ , Catherine Maiteki-Sebuguzi⁵ , Tamara D Clark³ , Bridget Nzarubara⁵ , Denise Njama-Meya⁵ , Arthur Mpimbaza⁵ , Philip J Rosenthal³ , Moses R Kamya⁵ , Fred Wabwire-Mangen⁶ , Grant Dorsey² and Ambrose O Talisuna⁷

¹London School of Hygiene & Tropical Medicine, London, UK

²c/o MU-UCSF Research Collaboration, Mulago Hospital Complex, P.O. Box 7475, Kampala, Uganda

³Department of Medicine, San Francisco General Hospital, University of California, San Francisco, USA

⁴Uganda Malaria Surveillance Project, Kampala, Uganda

⁵Makerere University Medical School, Kampala, Uganda

⁶Makerere University, School of Public Health, Kampala, Uganda

⁷Ministry of Health, Kampala, Uganda